Get started
Author

Joseph S. Koopmeiners

Observed names: J S Koopmeiners, J. Koopmeiners, JOSEPH S. KOOPMEINERS, Joseph S. Koopmeiners, Joseph Koopmeiners, Joseph S Koopmeiners, Joseph Stephen Koopmeiners, Koopmeiners, Joseph, Koopmeiners, Joseph S, Koopmeiners, Joseph S.
Observed institutions: National Institutes of Health, University of Minnesota, Pennsylvania State University, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, University of Pittsburgh, University of Washington, University of Minnesota System, Fred Hutch Cancer Center, National Human Genome Research Institute, University of Minnesota, Duluth, Masonic Cancer Center, Hamline University
ORCID: 0000-0001-6147-3168
Observed ORCID: 0000-0001-6147-3168
OpenAlex ID: A5023499017
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
2009 · Rosalind A Eeles, The UK ProtecT Study Collaborators, et al. · Nature Genetics · 418
Randomized Trial of Reduced-Nicotine Standards for Cigarettes
2015 · Eric C. Donny, Rachel L. Denlinger, et al. · New England Journal of Medicine · 407
PDF
Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure
2018 · Dorothy K. Hatsukami, Xianghua Luo, et al. · JAMA · 165
PDF
Prostate Cancer Specific Mortality and Gleason 7 Disease Differences in Prostate Cancer Outcomes Between Cases With Gleason 4 + 3 and Gleason 3 + 4 Tumors in a Population Based Cohort
2009 · Jonathan L. Wright, Claudia A. Salinas, et al. · The Journal of Urology · 161
Multiple Novel Prostate Cancer Predisposition Loci Confirmed by an International Study: The PRACTICAL Consortium
2008 · Zsofia Kote-Jarai, Douglas F. Easton, et al. · Cancer Epidemiology Biomarkers & Prevention · 161
Mobile Phone Text Messaging Intervention for Cervical Cancer Screening: Changes in Knowledge and Behavior Pre-Post Intervention
2014 · Hee Yun Lee, Joseph S Koopmeiners, et al. · Journal of Medical Internet Research · 135
PDF
An Alternative Formula to the Cockcroft-Gault and the Modification of Diet in Renal Diseases Formulas in Predicting GFR in Individuals with Type 1 Diabetes
2005 · Hassan Ibrahim, Michael Mondress, et al. · Journal of the American Society of Nephrology · 127
Vitamin D pathway gene variants and prostate cancer prognosis
2010 · Sarah K. Holt, Erika M. Kwon, et al. · The Prostate · 89
Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study
2009 · Ilir Agalliu, Erika M. Kwon, et al. · Cancer Causes & Control · 86
Multiple Independent Genetic Variants in the 8q24 Region Are Associated with Prostate Cancer Risk
2008 · Claudia A. Salinas, Erika Kwon, et al. · Cancer Epidemiology Biomarkers & Prevention · 83
PDF
Bayesian hierarchical modeling based on multisource exchangeability
2017 · Alexander M Kaizer, Joseph S Koopmeiners, et al. · Biostatistics · 80
PDF
mHealth Pilot Study: Text Messaging Intervention to Promote HPV Vaccination
2015 · Hee Yun Lee, Joseph S. Koopmeiners, et al. · American Journal of Health Behavior · 80
Clinical utility of five genetic variants for predicting prostate cancer risk and mortality
2008 · Claudia A. Salinas, Joseph S. Koopmeiners, et al. · The Prostate · 79
A multiplex platform for the identification of ovarian cancer biomarkers
2017 · Kristin L. M. Boylan, Kate Geschwind, et al. · Clinical Proteomics · 72
PDF
The association of cyclic parenteral nutrition and decreased incidence of cholestatic liver disease in patients with gastroschisis
2009 · Aaron R. Jensen, Adam B. Goldin, et al. · Journal of Pediatric Surgery · 70
Analysis of Recently Identified Prostate Cancer Susceptibility Loci in a Population-based Study: Associations with Family History and Clinical Features
2009 · Liesel M. FitzGerald, Erika M. Kwon, et al. · Clinical Cancer Research · 69
PDF
Activation of the FGFR–STAT3 Pathway in Breast Cancer Cells Induces a Hyaluronan-Rich Microenvironment That Licenses Tumor Formation
2013 · Laura R. Bohrer, Pavlina Chuntova, et al. · Cancer Research · 68
A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19
2021 · Michael A. Puskarich, Nathan W. Cummins, et al. · EClinicalMedicine · 67
PDF
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60
PDF
4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol and its Glucuronides in the Urine of Infants Exposed to Environmental Tobacco Smoke
2006 · Stephen S. Hecht, Steven G. Carmella, et al. · Cancer Epidemiology Biomarkers & Prevention · 59
Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer
2005 · Arkadiusz Z. Dudek, Krzysztof Lesniewski- Kmak, et al. · Lung Cancer · 59
Efficacy of Losartan in Hospitalized Patients With COVID-19–Induced Lung Injury
2022 · Michael A. Puskarich, Nicholas E. Ingraham, et al. · JAMA Network Open · 58
PDF
Effects of 6-Week Use of Reduced-Nicotine Content Cigarettes in Smokers With and Without Elevated Depressive Symptoms
2016 · Jennifer W. Tidey, Lauren R. Pacek, et al. · Nicotine & Tobacco Research · 58
PDF
Compensatory Smoking from Gradual and Immediate Reduction in Cigarette Nicotine Content
2014 · Dorothy K. Hatsukami, Eric C. Donny, et al. · Cancer Epidemiology Biomarkers & Prevention · 58
Detection of Prostate Cancer: Quantitative Multiparametric MR Imaging Models Developed Using Registered Correlative Histopathology
2016 · Gregory J. Metzger, Chaitanya Kalavagunta, et al. · Radiology · 56
Works count: 225
Citation count: 4,608
H-index: 37
I10-index: 84
Year
Topic
Type